These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 7482341)

  • 1. [Permixon in the treatment of benign prostatic hyperplasia].
    Gorilovskiĭ LM
    Ter Arkh; 1995; 67(8):62-4. PubMed ID: 7482341
    [No Abstract]   [Full Text] [Related]  

  • 2. [Alternative therapy of benign prostatic hypertrophy--Permixon (Capistan)].
    Hanus M; Matousková M
    Rozhl Chir; 1993 Feb; 72(2):75-9. PubMed ID: 7692609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The value of permixon in benign prostatic hypertrophy.
    Reece Smith H; Memon A; Smart CJ; Dewbury K
    Br J Urol; 1986 Feb; 58(1):36-40. PubMed ID: 2418902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Morphological changes in prostatic tissue of patients with benign prostatic hyperplasia treated with permixon].
    Sivkov AV; Kudriavtsev IuV; Medvedev AA; Razumov SV; Kochetov SA
    Urologiia; 2004; (5):10-6. PubMed ID: 15560155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Updated meta-analysis of clinical trials of Serenoa repens extract in the treatment of symptomatic benign prostatic hyperplasia.
    Boyle P; Robertson C; Lowe F; Roehrborn C
    BJU Int; 2004 Apr; 93(6):751-6. PubMed ID: 15049985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Saw palmetto extract: newest (and oldest) treatment alternative for men with symptomatic benign prostatic hyperplasia.
    Marks LS; Tyler VE
    Urology; 1999 Mar; 53(3):457-61. PubMed ID: 10096366
    [No Abstract]   [Full Text] [Related]  

  • 7. Proven and unproven therapy for benign prostatic hyperplasia.
    DiPaola RS; Morton RA
    N Engl J Med; 2006 Feb; 354(6):632-4. PubMed ID: 16467551
    [No Abstract]   [Full Text] [Related]  

  • 8. [The conservative treatment of early-stage benign prostatic hypertrophy].
    Kumanov Kh; Stoianova V; Lilov A; Kaloianov D
    Khirurgiia (Sofiia); 1993; 46(5):5-6. PubMed ID: 7527092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Saw palmetto fruit extract for treatment of benign prostatic hyperplasia. Results of a placebo-controlled double-blind study].
    Bauer HW; Casarosa C; Cosci M; Fratta M; Blessmann G
    MMW Fortschr Med; 1999 Jun; 141(25):62. PubMed ID: 10897913
    [No Abstract]   [Full Text] [Related]  

  • 10. Meta-analysis of clinical trials of permixon in the treatment of symptomatic benign prostatic hyperplasia.
    Boyle P; Robertson C; Lowe F; Roehrborn C
    Urology; 2000 Apr; 55(4):533-9. PubMed ID: 10736497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Our experience with a hexane extract of Serenoa repens in the treatment of benign prostatic hypertrophy].
    Ollé Carreras J
    Arch Esp Urol; 1987 Jun; 40(5):310-3. PubMed ID: 2444169
    [No Abstract]   [Full Text] [Related]  

  • 12. Comment on the appropriateness of The Prostate publishing a trial comparing Permixon to finasteride without a placebo control group.
    Gillenwater JY
    Prostate; 1998 Nov; 37(3):194. PubMed ID: 9792137
    [No Abstract]   [Full Text] [Related]  

  • 13. Saw palmetto for benign prostatic hyperplasia.
    McKinney DE
    JAMA; 1999 May; 281(18):1699. PubMed ID: 10328068
    [No Abstract]   [Full Text] [Related]  

  • 14. Serenoa repens treatment modifies bax/bcl-2 index expression and caspase-3 activity in prostatic tissue from patients with benign prostatic hyperplasia.
    Vela-Navarrete R; Escribano-Burgos M; Farré AL; García-Cardoso J; Manzarbeitia F; Carrasco C
    J Urol; 2005 Feb; 173(2):507-10. PubMed ID: 15643230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and tolerability of the lipidosterolic extract of Serenoa repens (Permixon) in benign prostatic hyperplasia: a double-blind comparison of two dosage regimens.
    Stepanov VN; Siniakova LA; Sarrazin B; Raynaud JP
    Adv Ther; 1999; 16(5):231-41. PubMed ID: 10915398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Serenoa repens--the saw palmetto or dwarf palm].
    Swoboda H; Kopp B
    Wien Med Wochenschr; 1999; 149(8-10):235. PubMed ID: 10483689
    [No Abstract]   [Full Text] [Related]  

  • 17. [Five-year experience in treating patients with prostatic hyperplasia patients with permixone (Serenoa repens "Pierre Fabre Medicament)].
    Aliaev IuG; Vinarov AZ; Lokshin KL; Spivak LG
    Urologiia; 2002; (1):23-5. PubMed ID: 11877967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What is saw palmetto used for, and does it interact with any medications?
    Gerber G
    Health News; 2000 Jun; 6(6):10. PubMed ID: 10917733
    [No Abstract]   [Full Text] [Related]  

  • 19. Saw palmetto for benign prostatic hyperplasia.
    Dimitrakov JD
    N Engl J Med; 2006 May; 354(18):1950-1; author reply 1950-1. PubMed ID: 16673527
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparative effects of alfuzosin versus Serenoa repens in the treatment of symptomatic benign prostatic hyperplasia.
    Grasso M; Montesano A; Buonaguidi A; Castelli M; Lania C; Rigatti P; Rocco F; Cesana BM; Borghi C
    Arch Esp Urol; 1995; 48(1):97-103. PubMed ID: 7537488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.